Structure-guided directed evolution of highly selective p450-based magnetic resonance imaging sensors for dopamine and serotonin.

[1]  I. Solomon.  Relaxation Processes in a System of Two Spins , 1955 .

[2]  Nicolaas Bloembergen,et al.  Proton Relaxation Times in Paramagnetic Solutions , 1957 .

[3]  T. Omura,et al.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. II. SOLUBILIZATION, PURIFICATION, AND PROPERTIES. , 1964, The Journal of biological chemistry.

[4]  R. Estabrook,et al.  Spectral studies of drug interaction with hepatic microsomal cytochrome. , 1967, Molecular pharmacology.

[5]  B. Griffin,et al.  Pseudomonas putida cytochrome P-450. The effect of complexes of the ferric hemeprotein on the relaxation of solvent water protons. , 1975, The Journal of biological chemistry.

[6]  S. Sligar,et al.  Coupling of spin, substrate, and redox equilibria in cytochrome P450. , 1976, Biochemistry.

[7]  S. Philson,et al.  The effect of cytochrome P-450cam on the NMR relaxation rate of water protons. , 1979, The Journal of biological chemistry.

[8]  R. Wightman,et al.  Direct in vivo monitoring of dopamine released from two striatal compartments in the rat. , 1983, Science.

[9]  L. Vickery,et al.  NMR studies of cytochrome P-450scc. Effects of steroid binding on water proton access to the active site of the ferric enzyme. , 1987, Biochemistry.

[10]  D. E. Anderson,et al.  Expression and nitrogen-15 labeling of proteins for proton and nitrogen-15 nuclear magnetic resonance. , 1989, Methods in enzymology.

[11]  D. Tank,et al.  Brain magnetic resonance imaging with contrast dependent on blood oxygenation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Ogawa.  Brain magnetic resonance imaging with contrast-dependent oxygenation , 1990 .

[13]  C. W. Fisher,et al.  High‐level expression of functional human cytochrome P450 1A2 in Escherichia coli , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[15]  C. Fewtrell,et al.  Paracrine Ca2+ signaling in vitro: Serotonin—mediated cell—cell communication in mast cell/smooth muscle cocultures , 1994, Journal of cellular physiology.

[16]  J. Dunitz.  The entropic cost of bound water in crystals and biomolecules. , 1994, Science.

[17]  J. M. Boyle,et al.  NMR studies of substrate binding to cytochrome P450 BM3: comparisons to cytochrome P450 cam. , 1995, Biochemistry.

[18]  W U Primrose,et al.  A model for human cytochrome P450 2D6 based on homology modeling and NMR studies of substrate binding. , 1996, Biochemistry.

[19]  D. Goldfarb,et al.  Study of Water Binding to Low-Spin Fe(III) in Cytochrome P450 by Pulsed ENDOR and Four-Pulse ESEEM Spectroscopies , 1996 .

[20]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[21]  J. Kuchtey,et al.  Correlating Ca2+ Responses and Secretion in Individual RBL-2H3 Mucosal Mast Cells* , 1997, The Journal of Biological Chemistry.

[22]  A. Vagin,et al.  MOLREP: an Automated Program for Molecular Replacement , 1997 .

[23]  W. Webb,et al.  Measuring Serotonin Distribution in Live Cells with Three-Photon Excitation , 1997, Science.

[24]  G. Miller,et al.  Elucidation of distinct ligand binding sites for cytochrome P450 3A4. , 2000, Biochemistry.

[25]  I. Bertini,et al.  1H NMRD profiles of diamagnetic proteins: a model‐free analysis † , 2000 .

[26]  T. Ost,et al.  Rational re‐design of the substrate binding site of flavocytochrome P450 BM3 , 2000, FEBS letters.

[27]  M. Machius,et al.  Pivotal role of water in the mechanism of P450BM-3. , 2001, Biochemistry.

[28]  J. Malone,et al.  Attractive intramolecular edge-to-face aromatic interactions in flexible organic molecules. , 2001, Accounts of chemical research.

[29]  G. Brainard,et al.  Action Spectrum for Melatonin Regulation in Humans: Evidence for a Novel Circadian Photoreceptor , 2001, The Journal of Neuroscience.

[30]  Annick Thomas,et al.  Aromatic side‐chain interactions in proteins. II. Near‐ and far‐sequence Phe‐X pairs , 2002, Proteins.

[31]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[32]  Frances H Arnold,et al.  Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3. , 2003, Journal of the American Chemical Society.

[33]  C. Otey.  High-throughput carbon monoxide binding assay for cytochromes p450. , 2003, Methods in molecular biology.

[34]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[35]  M. Joyce,et al.  A Single Mutation in Cytochrome P450 BM3 Induces the Conformational Rearrangement Seen upon Substrate Binding in the Wild-type Enzyme* , 2004, Journal of Biological Chemistry.

[36]  E. Ahrens,et al.  A new transgene reporter for in vivo magnetic resonance imaging , 2005, Nature Medicine.

[37]  P. Schultz,et al.  The incorporation of a photoisomerizable amino acid into proteins in E. coli. , 2006, Journal of the American Chemical Society.

[38]  P. Schultz,et al.  Structural plasticity of an aminoacyl-tRNA synthetase active site. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[39]  F. Arnold,et al.  Protein stability promotes evolvability. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[40]  F. Arnold,et al.  Enantioselective alpha-hydroxylation of 2-arylacetic acid derivatives and buspirone catalyzed by engineered cytochrome P450 BM-3. , 2006, Journal of the American Chemical Society.

[41]  P. Evans,et al.  Scaling and assessment of data quality. , 2006, Acta crystallographica. Section D, Biological crystallography.

[42]  A. Kabanov,et al.  Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85. , 2006, Molecular pharmaceutics.

[43]  K. Lesch,et al.  Long story short: the serotonin transporter in emotion regulation and social cognition , 2007, Nature Neuroscience.

[44]  Alan Jasanoff,et al.  MRI contrast agents for functional molecular imaging of brain activity , 2007, Current Opinion in Neurobiology.

[45]  W. Schultz.  Multiple dopamine functions at different time courses. , 2007, Annual review of neuroscience.

[46]  F. Arnold,et al.  A diverse family of thermostable cytochrome P450s created by recombination of stabilizing fragments , 2007, Nature Biotechnology.

[47]  Daniel V Santi,et al.  Total synthesis of multi-kilobase DNA sequences from oligonucleotides , 2007, Nature Protocols.

[48]  Keren Ziv,et al.  MRI detection of transcriptional regulation of gene expression in transgenic mice , 2007, Nature Medicine.

[49]  H. Toogood,et al.  Structural and Spectroscopic Characterization of P450 BM3 Mutants with Unprecedented P450 Heme Iron Ligand Sets , 2007, Journal of Biological Chemistry.

[50]  Frances H Arnold,et al.  Evolutionary history of a specialized p450 propane monooxygenase. , 2008, Journal of molecular biology.

[51]  Dennis S. Charney,et al.  Neurobiological mechanisms in major depressive disorder , 2009, Canadian Medical Association Journal.

[52]  F. Arnold,et al.  A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds. , 2009, Chemistry.

[53]  W. Kabsch.  XDS , 2010, Acta crystallographica. Section D, Biological crystallography.

[54]  Jasmine L. Gallaher,et al.  Computational Design of an Enzyme Catalyst for a Stereoselective Bimolecular Diels-Alder Reaction , 2010, Science.

[55]  J. Andrew McCammon,et al.  How Can Hydrophobic Association Be Enthalpy Driven? , 2010, Journal of chemical theory and computation.

[56]  Yosephine Gumulya,et al.  Iterative saturation mutagenesis accelerates laboratory evolution of enzyme stereoselectivity: rigorous comparison with traditional methods. , 2010, Journal of the American Chemical Society.

[57]  Dan S. Tawfik,et al.  Enzyme promiscuity: a mechanistic and evolutionary perspective. , 2010, Annual review of biochemistry.

[58]  M. Fukunaga,et al.  Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast , 2010, Proceedings of the National Academy of Sciences.

[59]  R. Baron,et al.  Water in Cavity−Ligand Recognition , 2010, Journal of the American Chemical Society.

[60]  Susannah J Tye,et al.  Wireless Instantaneous Neurotransmitter Concentration System: electrochemical monitoring of serotonin using fast-scan cyclic voltammetry--a proof-of-principle study. , 2010, Journal of neurosurgery.

[61]  Alan Jasanoff,et al.  Challenges for molecular neuroimaging with MRI , 2010, Int. J. Imaging Syst. Technol..

[62]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[63]  Mikhail G. Shapiro,et al.  Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamine , 2010, Nature Biotechnology.

[64]  Vlada B Urlacher,et al.  Screening of a minimal enriched P450 BM3 mutant library for hydroxylation of cyclic and acyclic alkanes. , 2011, Chemical communications.

[65]  H. Lester,et al.  Neural Systems Governed by Nicotinic Acetylcholine Receptors: Emerging Hypotheses , 2011, Neuron.

[66]  F. Arnold,et al.  Metal-substituted protein MRI contrast agents engineered for enhanced relaxivity and ligand sensitivity. , 2011, Journal of the American Chemical Society.